S.LAB (SOLOWAYS)
Quick facts
Phase 3 pipeline
- GcMAF injections (100 ng) · Oncology / Immunology
GcMAF (Gc-protein derived macrophage activating factor) activates macrophages to enhance immune surveillance and anti-tumor activity.
Phase 1 pipeline
- A standard antispasmodic · Gastroenterology
Blocks acetylcholine receptors to relax smooth muscle - EF-M2
- GcMAF
- hDNAgr Therapy
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: